- About Us
- Services & Solutions
- Novel Technology Platform
- Bioconjugation Discovery
- Bioconjugation Process Development
- Analytical Development
- Formulation and DP Development
- GMP mAb Intermediate and Conjugation Manufacturing
- GMP Formulation, Fill and Lyophilization
- Payload and Linker R&D and Manufacturing
- Ready-Made Payloads & Linkers
- WuXi XDC Singapore Site
- Investor Relations
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
Your Single Source for Bioconjugate Discovery, Development and Manufacturing
We are a fully integrated CRDMO specializing in bioconjugates, offering seamless, end-to-end solutions from discovery through to commercial manufacturing. Our one-stop comprehensive capabilities and innovative technology platform enable the development of ADCs and novel bioconjugate modalities, including dual payload ADCs(dpADCs), antibody peptide conjugates(APCs), bispecific antibody drug conjugates(BsADCs), antibody radionuclide conjugates(ARCs), and other novel conjugates. Our truly single-source solution greatly simplifies bioconjugate development and empowers global partners to bring complex bioconjugate therapeutics to market with reduced time, cost and risks.
Our capabilities span from ADCs to XDCs
Novel bioconjugates extending beyond conventional ADCs pose unprecedented challenges and uncertainties due to their modality complexity. At WuXi XDC, we leverage innovative technology platform and integrated end-to-end solutions to navigate the entire process from discovery to manufacturing. Join us in transforming breakthrough ideas into impactful therapies and shaping the future of bioconjugates.
- ADC/BsADC/Dual Payload ADC
- Antibody-Oligonucleotide Conjugate
- Antibody-Chelator Conjugate
- Degrader Antibody Conjugate
- Immuno-Stimulant Antibody Conjugate
- Antibody-Peptide Conjugate
- Vaccine Conjugate
- PEGylation-Based Conjugate
- Protein-Protein Conjugate
- Antibody-Glycan Conjugate
- Antibody-Fluorophore Conjugate
- Peptide-Oligo Conjugate
- and more…
Frontier Technology Platform for Bioconjugates
Conjugation and Payload-Linker Technology Innovation
The path to bioconjugates success demands precision—from DAR optimization and linker stability to rigorous safety profiling. At WuXi XDC, we recognize the transformative potential of bioconjugates and are committed to turning promise into reality. Leveraging our proprietary technologies, we have built a robust foundation for advanced bioconjugate development. Beyond our internal capabilities, we are actively forging and expanding partnerships with leading industry players. Through these collaborations, we continuously enrich and refine our technology platform, we don’t just support your journey—we propel it forward, accelerating breakthroughs at every stage.
Conjugation Technologies
- Conjugation technology for interchain cystine conjugation, enabling highly homogeneous ADCs and exceptional flexibility in DAR ratios.
Novel Payload-Linkers
Proprietary designed payload-linkers,
featuring enhanced plasma stability and better safety.
Knowledge Center
Our Offering
